J
Jacques Bille
Researcher at University of Lausanne
Publications - 244
Citations - 27030
Jacques Bille is an academic researcher from University of Lausanne. The author has contributed to research in topics: Fluconazole & Candida albicans. The author has an hindex of 80, co-authored 241 publications receiving 25458 citations. Previous affiliations of Jacques Bille include University Hospital of Lausanne.
Papers
More filters
Journal ArticleDOI
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben E. De Pauw,Thomas J. Walsh,J. Peter Donnelly,David A. Stevens,John E. Edwards,Thierry Calandra,Peter G. Pappas,Johan Maertens,Olivier Lortholary,Carol A. Kauffman,David W. Denning,Thomas F. Patterson,Georg Maschmeyer,Jacques Bille,William E. Dismukes,Raoul Herbrecht,William W. Hope,Christopher C. Kibbler,Bart Jan Kullberg,Kieren A. Marr,Patricia Muñoz,Frank C. Odds,John R. Perfect,Angela Restrepo,Markus Ruhnke,Brahm H. Segal,Jack D. Sobel,Tania C. Sorrell,Claudio Viscoli,John R. Wingard,Theoklis E. Zaoutis,John E. Bennett +31 more
TL;DR: These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.
Journal ArticleDOI
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
Oliver A. Cornely,Matteo Bassetti,Thierry Calandra,Jorge Garbino,Bart Jan Kullberg,O. Lortholary,O. Lortholary,Wouter Meersseman,Murat Akova,Maiken Cavling Arendrup,S. Arikan-Akdagli,Jacques Bille,Elio Castagnola,Manuel Cuenca-Estrella,J.P. Donnelly,Andreas H. Groll,Raoul Herbrecht,William W. Hope,Henrik Jeldtoft Jensen,Cornelia Lass-Flörl,George Petrikkos,Malcolm Richardson,Emmanuel Roilides,Paul E. Verweij,Claudio Viscoli,Andrew J. Ullmann +25 more
TL;DR: This part of the EFISG guidelines focuses on non-neutropenic adult patients, and liposomal amphotericin B and voriconazole are supported with moderate, and fluconazole with marginal strength for the targeted initial treatment of candidaemia.
Journal ArticleDOI
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
TL;DR: Voriconazole therapeutic drug monitoring improves the efficacy and safety of therapy in severely ill patients with invasive mycoses and aids in prompt and complete neurological recovery.
Journal ArticleDOI
Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
TL;DR: It is found that overexpression of the gene encoding 14DM either by gene amplification or by gene deregulation was not the major cause of resistance among these clinical isolates of fluconazole-resistant C. albicans, and that resistance could be mediated by energy-requiring efflux pumps such as ATP-binding cassette (ABC) multidrug transporters.
Journal ArticleDOI
EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.
J. L. Rodriguez-Tudela,Maiken Cavling Arendrup,Francesco Barchiesi,Jacques Bille,Erja Chryssanthou,Manuel Cuenca-Estrella,Eric Dannaoui,David W. Denning,J.P. Donnelly,Françoise Dromer,W. Fegeler,Cornelia Lass-Flörl,Caroline B. Moore,Malcolm Richardson,Per Sandven,Aristea Velegraki,Paul E. Verweij +16 more
TL;DR: A Reference Laboratory for Mycology and Parasitology, National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda, Spain.